Lymphangiogenesis in Gastric Cancer regulated through Akt/mTOR-VEGF-C/VEGF-D axis

被引:46
作者
Chen, Hongxia [1 ]
Guan, Runnian [2 ]
Lei, Yupeng [1 ]
Chen, Jianyong [3 ]
Ge, Qi [1 ]
Zhang, Xiaoshen [4 ,5 ]
Dou, Ruoxu [4 ,5 ]
Chen, Hongyuan [6 ]
Liu, Hao [4 ,5 ]
Qi, Xiaolong [1 ,4 ,5 ]
Zhou, Xiaodong [1 ]
Chen, Changyan [1 ,7 ]
机构
[1] Nanchang Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanchang 330006, Peoples R China
[2] Kaiping Cent Hosp, Dept Gastroenterol, Kaiping 529300, Peoples R China
[3] Jiangxi Prov Peoples Hosp, Dept Gastroenterol, Nanchang 330006, Peoples R China
[4] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA
[5] Harvard Univ, Sch Med, Boston, MA USA
[6] Guangdong Pharmaceut Univ, Sch Basic Course, Dept Pathogen Biol & Immunol, Guangzhou 510060, Guangdong, Peoples R China
[7] Northeastern Univ, Ctr Drug Discovery, Boston, MA 02115 USA
基金
美国国家科学基金会;
关键词
Lymphangiogenesis; Gastric cancer; Akt/mTOR; VEGF; ENDOTHELIAL GROWTH-FACTOR; LYMPH-NODE METASTASIS; FACTOR-C; PHOSPHORYLATED AKT; MAMMALIAN TARGET; FACTOR (VEGF)-C; VESSEL DENSITY; KINASE-B; EXPRESSION; PROGNOSIS;
D O I
10.1186/s12885-015-1109-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Lymphangiogenesis plays a significant role in metastasis and recurrence of gastric cancer. There is no report yet focusing on the modulation of VEGF pathway and lymphangiogenesis of gastric cancer by targeting Akt/mTOR pathway. This study aims to demonstrate the relationship between Akt/mTOR pathway and VEGF-C/-D in gastric cancer. Methods: We collected surgically resected gastric adenocarcinoma specimens from 55 consented patients. Immunohistochemistry staining of p-Akt, p-mTOR, VEGF-C, VEGF-D were performed and scored by two independent pathologists. The results were presented as staining intensity and positive staining cell rate. We also measured lymphatic vessel density (LVD) by D2-40 staining. Different dosages of p-Akt inhibitor LY294002 (12.5 mu M, 25 mu M, 50 mu M) and p-mTOR inhibitor Rapamycin (25 nM, 50 nM, 100 nM) were given to gastric cancer cell line SGC-7901 in vitro. The inhibition rate of cell growth was tested by MTT at 24 h, 48 h and 72 h, respectively and protein expressions of Akt, p-Akt, mTOR, p-mTOR, VEGF-C and VEGF-D were examined by Western blot. Results: The positive staining rates of p-Akt, p-mTOR, VEGF-C and VEGF-D in 55 gastric cancer clinical specimens were 74.54%, 85.45%, 72.73% and 58.18%. p-Akt and p-mTOR were positively correlated with VEGF-C and VEGF-D (p < 0.01). The LVD increased with incremental tendency of staining intensity of p-Akt, p-mTOR, VEGF-C and VEGF-D. LY294002 or Rapamycin significantly suppressed SGC-7901 cell growth and the inhibition rate was dose and time dependent (p < 0.001). In addition, the protein expression of p-Akt and p-mTOR were positively correlated with that of VEGF-C and VEGF-D (p < 0.05). Conclusions: The level of LVD in gastric cancer specimens was significant higher than that of normal gastric tissue and was positively correlated with p-Akt, p-mTOR, VEGF-C and VEGF-D. Inhibition of p-Akt and p-mTOR, in vitro, decreased tumor cell VEGF-C and VEGF-D significantly. Therefore, we concluded that lymphangiogenesis of gastric cancer might be related to Akt/mTOR-VEGF-C/VEGF-D axis.
引用
收藏
页数:7
相关论文
共 29 条
  • [1] Vascular Endothelial Growth Factor-C and -D Expression Correlates With Lymph Node Micrometastasis in pN0 Early Gastric Cancer
    Arigami, Takaaki
    Natsugoe, Shoji
    Uenosono, Yoshikazu
    Yanagita, Shigehiro
    Ehi, Katsuhiko
    Arima, Hideo
    Mataki, Yuko
    Nakajo, Akihiro
    Ishigami, Sumiya
    Aikou, Takashi
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2009, 99 (03) : 148 - 153
  • [2] Processes of Care in the Multidisciplinary Treatment of Gastric Cancer Results of a RAND/UCLA Expert Panel
    Brar, Savtaj S.
    Mahar, Alyson L.
    Helyer, Lucy K.
    Swallow, Carol
    Law, Calvin
    Paszat, Lawrence
    Seevaratnam, Rajini
    Cardoso, Roberta
    McLeod, Robin
    Dixon, Matthew
    Yohanathan, Lavanya
    Lourenco, Laercio G.
    Bocicariu, Alina
    Bekaii-Saab, Tanios
    Chau, Ian
    Church, Neal
    Coit, Daniel
    Crane, Christopher H.
    Earle, Craig
    Mansfield, Paul
    Marcon, Norman
    Miner, Thomas
    Noh, Sung Hoon
    Porter, Geoff
    Posner, Mitchell C.
    Prachand, Vivek
    Sano, Takeshi
    van de Velde, Cornelis
    Wong, Sandra
    Coburn, Natalie G.
    [J]. JAMA SURGERY, 2014, 149 (01) : 18 - 25
  • [3] Chen HF, 2014, ADVANCED CERAMICS FOR DENTISTRY, P5, DOI 10.1016/B978-0-12-394619-5.00002-X
  • [4] East meets west in the treatment of gastric cancer
    Cunningham, David
    Chua, Yu Jo
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (18) : 1863 - 1865
  • [5] The effect of the expression of vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 on the clinical outcome in patients with gastric carcinoma
    Han, F. -H.
    Li, H. -M.
    Zheng, D. -H.
    He, Y. -L.
    Zhan, W. -H.
    [J]. EJSO, 2010, 36 (12): : 1172 - 1179
  • [6] Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels
    He, YL
    Rajantie, I
    Pajusola, K
    Jeltsch, M
    Holopainen, T
    Yla-Herttuala, S
    Harding, T
    Jooss, K
    Takahashi, T
    Alitalo, K
    [J]. CANCER RESEARCH, 2005, 65 (11) : 4739 - 4746
  • [7] Variants on the promoter region of PTEN affect breast cancer progression and patient survival
    Heikkinen, Tuomas
    Greco, Dario
    Pelttari, Liisa M.
    Tommiska, Johanna
    Vahteristo, Pia
    Heikkila, Paivi
    Blomqvist, Carl
    Aittomaki, Kristiina
    Nevanlinna, Heli
    [J]. BREAST CANCER RESEARCH, 2011, 13 (06)
  • [8] Cancer statistics, 2007
    Jemal, Ahmedin
    Siegel, Rebecca
    Ward, Elizabeth
    Murray, Taylor
    Xu, Jiaquan
    Thun, Michael J.
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2007, 57 (01) : 43 - 66
  • [9] VEGF-D Promotes Tumor Metastasis by Regulating Prostaglandins Produced by the Collecting Lymphatic Endothelium
    Karnezis, Tara
    Shayan, Ramin
    Caesar, Carol
    Roufail, Sally
    Harris, Nicole C.
    Ardipradja, Kathryn
    Zhang, You Fang
    Williams, Steven P.
    Farnsworth, Rae H.
    Chai, Ming G.
    Rupasinghe, Thusitha W. T.
    Tull, Dedreia L.
    Baldwin, Megan E.
    Sloan, Erica K.
    Fox, Stephen B.
    Achen, Marc G.
    Stacker, Steven A.
    [J]. CANCER CELL, 2012, 21 (02) : 181 - 195
  • [10] Ko Yoon Ho, 2008, Cancer Res Treat, V40, P133, DOI 10.4143/crt.2008.40.3.133